Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Xbrane Biopharma - Filing #702449

Concept	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31
Disclosure of effect of changes in foreign exchange rates [text block]	—	—	—	—	—	—	—	—
Disclosure of information when currency is not exchangeable into another currency [text block]	—	—	—	—	—	—	—	—
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [text block]	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets	127 418 SEK	—	—	—	—	89 281 SEK	—	—
Current assets	561 008 SEK	—	—	—	—	374 482 SEK	—	—
Non-current liabilities	37 019 SEK	—	—	—	—	17 062 SEK	—	—
Current liabilities	219 667 SEK	—	—	—	—	188 993 SEK	—	—
Profit (loss) from continuing operations	—	—	183 226 SEK	—	—	—	218 126 SEK	—
Profit (loss) from discontinued operations	—	—	5 150 SEK	—	—	—	7 900 SEK	—
Profit (loss)	—	—	188 376 SEK	188 376 SEK	226 026 SEK	—	226 026 SEK	—
Other comprehensive income	—	1 220 SEK	1 220 SEK	—	—	—	2 774 SEK	2 774 SEK
Comprehensive income	—	1 220 SEK	187 156 SEK	188 376 SEK	226 026 SEK	—	228 800 SEK	2 774 SEK